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Abstract
The effect of the administration of modulators of different subtypes of K+ channels on antinociception induced by the tricyclic
antidepressants amitriptyline and clomipramine was evaluated in the mouse hot plate test. The administration of the voltage-gated
K+ channel blocker tetraethylammonium (0.01–0.5 m g per mouse i.c.v.) prevented antinociception induced by both amitriptyline
(15 mg kg21 s.c.) and clomipramine (25 mg kg21 s.c.). The KATP channel blocker gliquidone (0.1–1.0 m g per mouse i.c.v.) prevented
antinociception produced by amitriptyline and clomipramine whereas the KATP channel openers minoxidil (10 m g per mouse i.c.v.)
and pinacidil (25 m g per mouse i.c.v.) potentiated tricyclic antidepressant-induced analgesia. The administration of the Ca2+-gated
K+ channel blocker apamin (0.1–1.0 ng per mouse i.c.v.) completely prevented amitriptyline and clomipramine analgesia. At the
highest effective doses, none of the drugs used induced behavioural side effects or impaired motor coordination, as revealed by
the rota-rod test, spontaneous motility or inspection activity, as revealed by the hole board test. The present results demonstrate
that central antinociception induced by amitriptyline and clomipramine involves the opening of different subtypes of K+ channels
(voltage-gated, KATP and Ca2+-gated) which, therefore, represent a step in the transduction mechanism of tricyclic antidepressant
analgesia. Ó 2000 Elsevier Science Ltd. All rights reserved.
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Tricyclic antidepressants have long been known to
exert analgesic activity in laboratory animals (Murua and
Molina, 1991; Goldstein et al., 1990; Acton et al., 1992)
and to provide analgesia for a variety of neuropathic and
headache pain syndromes in humans regardless of the
presence of depression (Richeimer et al., 1997). The
analgesic effect of tricyclic antidepressant drugs seems
unrelated to their antidepressant action since the doses
used for analgesia are lower than those considered effec-
tive in the treatment of depression (Acton et al., 1992).
Furthermore, clinical trials have shown that the response
to tricyclic antidepressants of patients suffering from
chronic pain syndromes with coexisting diagnosis of
depression is similar to that of patients without docu-
mented depression (Richeimer et al., 1997).
Clomipramine and amitriptyline, as well as other tri-
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cyclic antidepressants, are inhibitors of serotonin reup-
take. The subsequent increase of endogenous serotonin
in the synaptic cleft has been supposed to be responsible
for the increase in the pain threshold of mice either
directly (Galeotti et al., 1995), or through activation of
the opioid system (Sacerdote et al., 1987).
The stimulation of 5-HT receptors can affect several
types of K+ channels in central neurones (Bobker and
Williams, 1990). Electrophysiological studies have
shown that a number of different types of K + channel
currents exist in mammalian neurones (Christie, 1995).
K + channels can be classified by their mechanism of
activation–inactivation. Among them are the voltage-
gated K+-channel currents which have been classified as
fast-activating A-type currents and slowly inactivating
delayed-rectifier type currents (Catterall, 1988; Jan and
Jan, 1989; Mathie et al., 1998). Other K + channels can
be modulated by neurotransmitters interacting with G-
protein-coupled receptors (Brown and Birnbaumer,
1990; Brown, 1990). G proteins can modulate different
types of K + channels through a direct effect on the ion
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channel or through an enzymatic step leading to the gen-
eration of cytoplasmic second messengers (Brown, 1990;
Hille, 1994). Various pharmacological compounds can
modulate these channels. Tetraethylammonium (TEA)
blocks different types of K + channels in neurones includ-
ing Ca2+-activated and voltage-dependent K + channels
(Cook and Quast, 1990; Halliwell, 1990). Apamin was
reported to block specifically currents through the Ca2+-
activated K + channels (Cook, 1988). Sulphonylureas
such as gliquidone, block KATP K + channels in neurones
whereas minoxidil and pinacidil open the same type
(KATP) of K+ channel (Edwards and Weston, 1993;
Longman and Hamilton, 1992).
Central K + channels appear to be involved in the
modulation of pain perception. The central adminis-
tration of K + channel openers, such as diazoxide, minox-
idil, lemakalim and cromakalim, has been reported to
produce antinociception in laboratory animals (Welch
and Dunlow, 1993; Narita et al., 1993) and to potentiate
the enhancement of the pain threshold produced by
opioid and a 2-adrenoceptor agonists (Vergoni et al.,
1992; Ocan˜a et al., 1996). Furthermore, treatment with
K + channel blockers, such as sulphonylureas, 4-aminop-
yridine and tetraethylammonium, prevented the antinoc-
iception induced by a 2-adrenoceptor, GABAB and opioid
receptor agonists (Ocan˜a and Baeyens, 1993; Raffa and
Martinez, 1995).
Recently, it has been reported that the administration
of an antisense oligonucleotide which selectively
inhibited the expression of the gene coding for the volt-
age-gated K + channel mKv1.1, prevented analgesia
induced by tricyclic antidepressants (Galeotti et al.,
1997). Since little is known about the intracellular effec-
tors involved in the mechanism of analgesic action of
tricyclic antidepressants, we decided to investigate
further the role of K + channels in the enhancement of
the pain threshold induced by the tricyclic antidepressant
drugs amitriptyline and clomipramine.
1. Methods
1.1. Animals
Male Swiss albino mice (23–30 g) from Morini (San
Polo d’Enza, Italy) were used. The mice were housed
15 per cage. The cages were placed in the experimental
room 24-h before the test, for adaptation. The animals
were fed a standard laboratory diet and tap water ad libi-
tum and kept at 23 – 1° C with a 12-h light/dark cycle,
light on at 7 a.m. Animals were used once only. All
experiments were carried out in accordance with the Eur-
opean Communities Council Directive of 24 November
1986 (86/609/EEC) for experimental animal care.
1.2. Intracerebroventricular injection technique
Intracerebroventricular (i.c.v.) administration was per-
formed under ether anaesthesia, according to the method
described by Haley and McCormick (1957). Briefly, dur-
ing anaesthesia, mice were grasped firmly by the loose
skin behind the head. A 0.4 mm external diameter hypo-
dermic needle attached to a 10 m l syringe was inserted
perpendicularly through the skull and no more than 2
mm into the brain of the mouse, where 5 m l were then
administered. The injection site was 1 mm to the right
or left from the midpoint on a line drawn through to the
anterior base of the ears. Injections were performed into
the right or left ventricle randomly. To ascertain that the
drugs were administered exactly into the cerebral ven-
tricle, some mice (20%) were injected with 5 m l of
diluted 1:10 India ink and their brains examined macro-
scopically after sectioning. The accuracy of the injection
technique was evaluated and the percentage of correct
injections was 95.
1.3. Hot plate test
O’Callaghan and Holtzman (1975) described the
method adopted. Mice were placed inside a stainless
steel container, which was set thermostatically at
52.5 – 0.1 ° C in a precision water-bath from KW Mechan-
ical Workshop, Siena, Italy. Reaction times (s), were
measured with a stopwatch before and 15, 30, 45 and 60
min after amitriptyline and clomipramine administration.
The endpoint used was the licking of the fore or hind
paws. Those mice scoring less than 12 or more than 18
s in the pre-test were rejected (30%). An arbitrary cut-
off time of 45 s was adopted.
The licking latency values reported in Figs. 2, 3 and
5 were evaluated in relation to the maximum analgesic
effect of amitriptyline and clomipramine, which was 30
min after administration.
1.4. Hole-board test
The hole board test set-up utilises a 40 cm square
plane with 16 flush-mounted cylindrical holes (diameter
3 cm) distributed 4 by 4 in an equidistant, grid-like man-
ner. The mice were placed in the centre of the board one
by one and left to move about freely for a period of 5
min each. Two photoelectric beams, crossing the plane
from mid-point to mid-point of opposite sides, thus
dividing the plane into 4 equal quadrants, automatically
signalled the movement of the animals on the surface of
the plane. Miniature photoelectric cells, in each of the
16 holes, recorded the exploration of the holes (head
plunging activity) by the mice.
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1.5. Rota-rod test
The apparatus consisted of a base platform and a rotat-
ing rod of 3 cm diameter with a non-slippery surface.
This rod was placed at a height of 15 cm from the base.
The rod, 30 cm in length, was divided into 5 equal sec-
tions by 6 disks. Thus up to 5 mice were tested simul-
taneously on the apparatus, with a rod-rotating speed of
16 r.p.m. The integrity of motor coordination was
assessed on the basis of endurance time of the animals
on the rotating rod according to the method described
by Kuribara et al. (1977). One day before the test, the
animals were trained twice. On the day of the test only
the mice that were able to stay balanced on the rotating
rod between 70 and 120 s (cut-off time) were selected
for testing. Performance time was measured before and
15, 30 and 45 min after s.c. administration of the investi-
gated compounds.
1.6. Drugs
The following drugs were used: clomipramine
(Anafranil, Ciba Geigy, Basel, Switzerland), amitripty-
line (Sigma, Milan, Italy), minoxidil, pinacidil, apamin,
tetraethylammonium (RBI, Milan, Italy); gliquidone
(Boehringer Ingelheim, Milan, Italy), d-amphetamine
(De Angeli, Rome, Italy).
Drugs were dissolved in isotonic (NaCl 0.9%) saline
solution, with the exception of pinacidil, that was dis-
solved in a water and dimethyl sulphoxide (DMSO) (3:1)
vehicle, immediately before use. Drug concentrations
were prepared in such a way that the necessary dose
could be administered in a volume of 5 m l per mouse
by i.c.v. injection and 10 ml kg21 by s.c. injection.
Apamin, gliquidone, minoxidil, pinacidil and TEA
were injected i.c.v. 15 min before the test. The drug
administration schedule was chosen on the basis of pre-
liminary experiments in which the time-course and the
dose–response curves in the hot-plate test for every com-
pound were determined.
1.7. Statistical analysis
All experimental results are given as the means –
SEM. An analysis of variance (ANOVA), followed by
Fisher’s Protected Least Significant Difference (PLSD)
procedure for post-hoc comparison, was used to verify
the significance of differences between two means. Data
were analysed with the StatView software for the Macin-
tosh.
2. Results
2.1. Effect of TEA on tricyclic antidepressant
antinociception
The effect produced by TEA, a blocker of voltage-
gated K + channels, on the enhancement of the pain thres-
hold produced by amitriptyline (15 mg kg21 s.c.) and
clomipramine (25 mg kg21 s.c.) was investigated in the
mouse hot-plate test. The administration of TEA (0.001–
0.5 m g per mouse i.c.v.) produced a dose-dependent pre-
vention of both amitriptyline (Fig. 1, panel A) and clomi-
pramine (Fig. 1, panel B) antinociception.
2.2. Effect of KATP channels modulators on tricyclic
antidepressant antinociception
The effect produced by the blocker (gliquidone) and
the openers (minoxidil, pinacidil) of KATP channels was
investigated on the enhancement of the pain threshold
produced by amitriptyline (15 mg kg21 s.c.) and clomip-
ramine (25 mg kg21 s.c.).
The administration of the KATP channel blocker gliqui-
done (0.01–1.0 m g per mouse i.c.v.), 15 min before the
mouse hot-plate test, prevented antinociception induced
by amitriptyline (Fig. 2, panel A) and clomipramine
(Fig. 2, panel B) in a dose-dependent manner.
Both KATP channel openers minoxidil (10 m g per
mouse i.c.v.) and pinacidil (25 m g per mouse i.c.v.),
injected 15 min before the test, potentiated the antino-
ciceptive activity of all the investigated tricyclic antide-
pressants (Fig. 3). A lower dose of minoxidil (1 m g per
mouse i.c.v.) and pinacidil (5 m g per mouse i.c.v.) was
ineffective (Fig. 3).
2.3. Effect of the Ca2+-activated K+ channel blocker
apamin on tricyclic antidepressant antinociception
The effect produced by the Ca2+-activated K + channel
blocker apamin on the enhancement of the pain threshold
induced by amitriptyline (15 mg kg21 s.c.; Fig. 4, panel
A) and clomipramine (25 mg kg21 s.c.; Fig. 4, panel B)
was investigated in mouse using the hot-plate test.
Apamin (0.01–1.0 ng per mouse i.c.v.), injected 15
min before the test, dose-dependently prevented the anti-
nociception induced by the tricyclic antidepressants
investigated as illustrated in Fig. 4.
Regression lines showing the dose-dependent inhi-
bition of amitriptyline and clomipramine antinociception
produced by increasing concentrations of TEA, gliqui-
done and apamin, are shown, as insets, respectively in
Figs. 1, 2 and 4. The licking latency values reported were
evaluated in relation to the maximum analgesic effect of
amitriptyline and clomipramine, which occurred 30 min
after administration.
2.4. Effect of K+ channels modulators on pain
threshold
The effect on the pain threshold produced by the
modulators of K + channels used was investigated by
using the mouse hot plate test. As reported in Table 1,
modulators of voltage-gated (TEA), Ca2+-gated (apamin)
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Fig. 1. Prevention of analgesia induced by amitriptyline (15 mg kg21 s.c.; panel A) and clomipramine (25 mg kg21 s.c.; panel B) by increasing
concentrations of TEA (0.001–0.5 m g per mouse i.c.v.) in the mouse hot-plate test. Mice were i.c.v. injected with saline or TEA 15 min before
the test. Vertical lines give SEM; there were 10–17 mice per group. *p,0.05, **p,0.01 in comparison with corresponding analgesic drug-treated
mice. Inset: dose-dependent prevention of amitriptyline (15 mg kg21 s.c., panel A) and clomipramine (25 mg kg21 s.c., panel B) analgesia by
increasing concentrations of TEA. The licking latency values were recorded 30 min after TCAs administration.
and KATP channels (gliquidone, minoxidil, pinacidil)
modified the licking latency values of mice when given
alone, having no hyperalgesic or analgesic effect.
The doses reported in Table 1 were the highest effec-
tive doses investigated for each compound.
2.5. Effect of antidepressants and K+-channel
modulators on mouse behaviour
Amitriptyline and clomipramine, at the doses used in
the present work, elicited their antinociceptive effect
without changing the gross behaviour of the mice. Simi-
larly, K + channel modulators exhibited their ability to
modulate enhancement of the pain threshold produced
by tricyclic antidepressants without inducing any behav-
ioural side effect.
All of the investigated compounds failed to alter the
motor coordination of the mice as revealed by the rota-
rod test (Table 2). The rota-rod endurance time of mice
treated with amitriptyline (15 mg kg21 s.c.), clomipram-
ine (25 mg kg21 s.c.), TEA (0.5 m g per mouse i.c.v.),
apamin (1.0 ng per mouse i.c.v.), gliquidone (1.0 m g per
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Fig. 2. Prevention of analgesia induced by amitriptyline (15 mg kg21 s.c.; panel A) and clomipramine (25 mg kg21 s.c.; panel B) by increasing
concentrations of gliquidone (0.01–1.0 m g per mouse i.c.v.) in the mouse hot-plate test. Mice were i.c.v. injected with saline or gliquidone 15 min
before the test. The licking latency values were evaluated 30 min after administration of TCAs. Vertical lines give SEM; there were 12–19 mice
per group. *p,0.05, **p,0.01 in comparison with corresponding analgesic drug-treated mice. Inset: dose-dependent prevention of amitriptyline
(15 mg kg21 s.c., panel A) and clomipramine (25 mg kg21 s.c., panel B) analgesia by increasing concentrations of gliquidone.
mouse i.c.v.) and minoxidil (10 m g per mouse i.c.v.),
was not modified in comparison with saline-treated mice
(Table 2). Similarly, the administration of pinacidil (25
m g per mouse i.c.v.) did not alter the motor coordination
in comparison with the vehicle-treated mice (Table 2).
By contrast, higher doses of amitriptyline (30 mg kg21
s.c.) and clomipramine (45 mg kg21 s.c.) impaired rota-
rod performances of mice (Table 2).
Furthermore, the concentrations of amitriptyline, clo-
mipramine, TEA, apamin, gliquidone, minoxidil and
pinacidil which did not alter motor coordination, were
also unable to modify either inspection activity (Fig. 5,
panel A) or spontaneous motility (Fig. 5, panel B) of
mice as revealed by the hole board test.
3. Discussion
The results reported in the present work indicate that
modulation of neuronal K + channels represents an essen-
tial step in the induction of analgesia by tricyclic antide-
pressants. Our results demonstrate that the adminis-
tration of K + channel blockers (TEA, apamin,
gliquidone) prevented the enhancement of mouse pain
threshold produced by the tricyclic antidepressants ami-
triptyline and clomipramine. In contrast, the K + channel
openers (minoxidil, pinacidil) potentiated the tricyclic
antidepressant-induced analgesia. Therefore, the K +
channel functionality appears fundamental in the mech-
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Fig. 3. Potentiation of analgesia induced by amitriptyline (AMI) (15 mg kg21 s.c.; panel A) and clomipramine (CLOMI) (25 mg kg21 s.c.; panel
B) by minoxidil (1–10 m g per mouse i.c.v.) and pinacidil (5–25 m g per mouse i.c.v.) in the mouse hot-plate test. Mice were i.c.v. injected 15 min
before the test. The licking latency values were evaluated 30 min after administration of TCAs. Vertical lines give SEM; there were 12–17 mice
per group. *p,0.05 in comparison with corresponding analgesic drug-treated mice.
anism of analgesic action of amitriptyline and clomipra-
mine.
At concentrations used in the present work, neither
the K + channel blockers (TEA, gliquidone, apamin), nor
the K + channel openers (minoxidil, pinacidil) used,
modified the licking latency values of mice in compari-
son with control groups. The lack of effect of TEA,
gliquidone and apamin agrees with results of studies in
which these compounds did not modify the nociceptive
threshold against thermal noxious stimuli (Welch and
Dunlow, 1993; Raffa and Martinez, 1995; Welch et al.,
1995) excluding that the prevention of amitriptyline and
clomipramine antinociception is due to a hyperalgesic
effect of the K + channel blockers used. The adminis-
tration of the K + channel opener minoxidil has been
reported to induce antinociception in the tail flick test,
but this effect was detectable only at doses higher than
those employed in the present study (Welch and Dun-
low, 1993). We can, therefore, rule out that the potenti-
ation of tricyclic antidepressant antinociception could be
subsequent to an enhancement of the pain threshold pro-
duced by the minoxidil and pinacidil. The lack of modi-
fication of the pain threshold by K + channels modulators
at concentrations able to prevent tricyclic antidepressant
analgesia, might also indicate that K + channels of neu-
rones involved in the modulation of pain perception are
not tonically activated.
The present results indicate the involvement of volt-
age-gated K + channels in the mechanism of analgesic
action of tricyclic antidepressants. The administration of
TEA, a blocker of voltage-gated K + channels (Cook and
Quast, 1990; Halliwell, 1990) dose-dependently pre-
vented the antinociception induced by amitriptyline and
clomipramine. These results are in agreement with pre-
vious data in which the lack of expression of the voltage-
gated K + channel mKv1.1 by i.c.v. administration of a
specific antisense oligonucleotide, prevented the antinoc-
iception induced by both amitriptyline and clomipramine
(Galeotti et al., 1997).
The important role played by KATP channels in the
capability of amitriptyline and clomipramine to enhance
the pain threshold is also shown. The administration of
gliquidone, a potent blocker of ATP-dependent K + chan-
nels (KATP) (Amoroso et al., 1990), prevented the antino-
ciception produced by the tricyclic antidepressants ami-
triptyline and clomipramine. Pretreatment with
minoxidil and pinacidil, openers of neuronal KATP chan-
nels (Longman and Hamilton, 1992), potentiated the
enhancement of the pain threshold produced by the
above-mentioned analgesic compounds. These results
suggest that opening of the KATP channels underlies the
antinociception induced by both tricyclic antidepressants
investigated. In the light of these considerations, it is
plausible to suggest that the potentiation of amitriptyline
and clomipramine antinociception induced by minoxidil
and pinacidil may occur because these compounds facili-
tate the opening of KATP channels induced by tricyclic
antidepressants.
The intracellular mechanism of analgesic action of
amitriptyline and clomipramine involves the activation
of a pertussis toxin (PTX)-sensitive G-protein, since
their analgesia is prevented by the i.c.v. administration
of PTX (Galeotti et al. 1996, 1997). PTX-sensitive G-
proteins (Gi) are responsible for modulation of ionic con-
ductance through a direct interaction with the ion chan-
nel and/or by lowering intracellular cyclic AMP levels
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Fig. 4. Prevention of analgesia induced by amitriptyline (15 mg kg21 s.c.) and clomipramine (25 mg kg21 s.c.) by increasing concentrations of
apamin (0.01–1 ng per mouse i.c.v.) in the mouse hot-plate test. Mice were i.c.v. injected 15 min before the test. Vertical lines give SEM; there were
11–18 mice per group. *p,0.05 in comparison with corresponding analgesic drug-treated mice. Inset: dose-dependent prevention of amitriptyline (15
mg kg21 s.c., panel A) and clomipramine (25 mg kg21 s.c., panel B) analgesia by increasing concentrations of apamin.
(Hille, 1994). The KATP channels can be opened through
a mechanism mediated by G-proteins. It has been
reported that the interaction between the a -GTP subunit
and the KATP channel produces a conformational change
that stimulates the opening of the channel (Edwards and
Weston, 1993). In the presence of GTP g S, a non-
hydrolysable GTP analogue, an irreversible activation of
KATP is obtained. Furthermore, the a subunits involved
in the modulation of KATP channel function have been
identified as belonging to the a i and a o subtypes
(Edwards and Weston, 1993). From this evidence, we
can suppose that KATP channels are involved in the anal-
gesia induced by amitriptyline and clomipramine as an
intracellular effector underlying the activation of a Gi
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Table 1
Effect of potassium channel modulators in the mouse hot-plate testa
Treatment (i.c.v.) Licking latency (s)
Before treatment After treatment
15 min 30 min 45 min 60 min
SALINE 15.9 – 0.8 15.2– 0.7 15.0– 0.9 14.8 – 0.9 14.4– 0.8
GLIQ 1 m g 15.2– 1.0 14.2– 1.2 14.9– 1.0 15.2 – 1.5 14.4– 1.3
APA 1 ng 16.0 – 1.4 15.2– 1.0 14.2– 1.4 14.0 – 1.1 14.9– 1.5
MIN 10 m g 15.8 – 1.3 15.9– 1.5 14.3– 0.9 14.5 – 1.4 14.3– 1.1
TEA 0.5 m g 15.6 – 1.2 14.7– 1.1 15.0– 1.3 14.8 – 1.3 14.2– 1.0
VEHICLE 15.3 – 1.6 14.5– 1.0 14.7– 1.1 14.3 – 0.9 14.5– 0.6
PIN 25 m g 15.5– 1.2 14.8– 0.9 15.5– 1.6 15.1 – 1.4 14.6– 0.9
a GLIQ: gliquidone; APA: apamin; MIN: minoxidil; TEA: tetraethylammonium; PIN: pinacidil. Data are reported as mean – SEM;
vehicle=H2O+DMSO (3:1).
Table 2
Effect of clomipramine, amitriptyline, TEA, apamin, gliquidone, minoxidil and pinacidil in the mouse rota-rod testa
Treatment Endurance time (s)
Before treatment After treatment
15 min 30 min 45 min
SALINE 104.1 – 7.3 101.8– 8.2 111.4– 7.0 107.8– 8.2
AMI (15 mg kg21 s.c.) 108.9 – 7.5 99.6– 7.2 104.2– 8.4 101.6– 7.4
AMI (30 mg kg21 s.c.) 109.6 – 6.5 39.2– 8.5b* 36.2 – 9.4* 67.6– 7.4*
CLO (25 mg kg21 s.c.) 112.6 – 7.1 101.2– 8.5 108.0– 9.6 110.1– 7.6
CLO (45 mg kg21 s.c.) 107.4 – 6.2 82.8– 10.4 63.6– 8.4* 93.5– 7.6
TEA (0.5 m g i.c.v.) 113.6 – 6.4 102.1– 7.1 111.1– 6.4 110.5– 07.2
APA (1 ng i.c.v.) 105.8 – 7.0 100.1– 7.5 108.4– 7.9 101.0– 8.3
GLIQ (1 m g i.c.v.) 103.4 – 7.4 99.8– 8.3 101.0– 7.4 110.8– 7.2
MIN (10 m g i.c.v.) 106.6 – 7.0 111.9– 8.4 105.9– 7.3 110.6– 7.2
VEHICLE 107.5 – 7.5 102.7– 8.2 112.3– 7.5 111.5– 6.4
PIN (25 m g i.c.v.) 103.8– 6.3 109.3– 7.4 100.1– 8.6 105.8– 7.3
a CLO: clomipramine; AMI: amitriptyline; TEA: tetraethylammonium; APA: apamin; GLIQ: gliquidone; MIN: minoxidil; PIN: pinacidil. Data
are reported as mean – SEM; vehicle: H2O+DMSO 3:1.
b *p,0.05 in comparison with saline-treated group.
protein. It is interesting to note that, in addition to the
present results concerning tricyclic antisepressants, KATP
channel blockers also prevented the antinociception
induced by other compounds which interact with Gi pro-
tein-coupled receptors, such as m - and d -opioid recep-
tors, adenosine A1 receptors, histamine H1 receptors, a 2
adrenoceptors (Ocan˜a et al., 1990; Wild et al., 1991;
Ocan˜a and Baeyens, 1994; Ghelardini et al., 1998; Gale-
otti et al., 1999). Taken together, these data indicate that
the opening of KATP channels is a signal transduction
mechanism common to analgesic drugs interacting with
Gi proteins.
The present study also provides evidence for the
involvement of Ca2+-gated K + channels in the antinoc-
iception induced by tricyclic antidepressants. The i.c.v.
administration of the bee venom apamin, a blocker of
small (low) conductance Ca2+-gated K + channels (Rudy,
1988), prevented the analgesia produced by amitriptyline
and clomipramine indicating the important role of Ca2+-
gated K + channels in the modulation of the pain thres-
hold produced by tricyclic antidepressants. TEA has
been reported to block not only voltage-dependent but
also Ca2+-activated K + channels (Cook and Quast, 1990;
Halliwell, 1990). The prevention of amitriptyline and
clomipramine antinociception by TEA administration
further supports the hypothesis of a Ca2+-gated K + chan-
nel role in the mechanism of analgesic action of tricyclic
antidepressants. These results are not in agreement with
previous data which reported that amitriptyline was a
weak inhibitor (20% inhibition) of the large conductance
Ca2+-activated K + channel (BKCa) activity in rat isolated
cortical neurones (Lee et al., 1997). However, this dis-
crepancy could be explained by considering that these
inhibitory effects were not identified as part of the mech-
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Fig. 5. Effect of amitriptyline (15 mg kg21 s.c.), clomipramine (25
mg kg21 s.c.), TEA (0.5 m g per mouse i.c.v.), apamin (1 ng per mouse
i.c.v.), gliquidone (1 m g per mouse i.c.v.), minoxidil (10 m g per mouse
i.c.v.), pinacidil (25 m g per mouse i.c.v.) in the mouse hole-board test.
The number of movements was detected 30 min after administration
of all drugs with the exception of d-amphetamine which was injected
15 min before the test. d-Amphetamine (2 mg kg21 s.c.) was used as
reference drug. Vertical lines give SEM; there were 9–12 mice per
group. *p,0.01 in comparison with saline-treated mice.
anism of antidepressant action, but this activity was sup-
posed to contribute to the induction of side effects asso-
ciated with tricyclic compound therapy (Lee et al.,
1997). It should also be noted that the doses of tricyclic
antidepressants used for analgesia are lower than those
considered effective in the treatment of depression
(Acton et al., 1992). It seems, unlikely therefore, that,
at analgesic doses, inhibitory actions on Ca2+-gated K +
channels, which represent undesirable side effects asso-
ciated with high dosage antidepressant therapy, could
appear.
The complete reversion of TCAs analgesia exerted by
the blockers of different types of potassium channels is
difficult to explain. In fact, it would be expected that
each blocking drug would only partially reverse the
effect of TCAs. However, even if we do not have any
convincing explanation for this particular effect, we can
assess that this is a general phenomenon produced by
potassium channel modulators. Potassium channel
blockers may increase the excitability of central circuits
so that, when pain responses are generated and these cir-
cuits fire, one can overcome the antinociceptive activity
of TCAs by increasing the excitability of the system.
Likewise, KATP openers would decrease the excitability
of central circuits by hyperpolarising cellular mem-
branes. However, the system is so complex that other
explanations could exist.
Amitriptyline and clomipramine exerted their antino-
ciceptive activity without showing any alteration of the
motor coordination of the mice as revealed by the rota-
rod test. Furthermore, the tricyclic antidepressants did
not modify the spontaneous motility and inspection
activity as revealed by the hole board test. However, the
administration of doses of amitriptyline and clomipram-
ine two times higher than those used in the present study
produced impairment of motor coordination whose
appearance could lead to a modification of the licking
latency values detected in the hot-plate test. In order to
avoid misinterpretation of data, it has been necessary to
limit the investigation to doses of amitriptyline and clo-
mipramine at which these compounds showed antino-
ciceptive properties without any behavioural side effect.
The potassium channel modulators, at the highest
doses used, did not modify the gross behaviour of the
animals. Moreover, these compounds did not impair
motor coordination as revealed by the rota rod test nor
modify locomotor and inspection activity as indicated by
the hole board test. Therefore, we can suppose that the
effects produced by potassium channel modulators can-
not be attributed to compromised behavioural paradigms.
Regarding the potassium channel blockers TEA and apa-
min, doses twice those able to completely prevent TCAs
analgesia, induced convulsions in mice.
In conclusion, the present data demonstrate that neu-
ronal K + channels represent an important intracellular
effector in the antinociceptive activity of tricyclic antide-
pressants. The modulation of voltage-gated, KATP and
Ca2+-gated K + channels is, in fact, able to modulate the
capability of amitriptyline and clomipramine to induce
analgesia.
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